MyAverix Finance
F · Healthcare
Racura Oncology Ltd (FN3)
Biotechnology
Racura Oncology Ltd (FN3) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $271.14M, P/E ratio is 18.00, net margin is -270.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for FN3
Racura Oncology Ltd (FN3) — FAQ
What is Racura Oncology Ltd's market cap?
Racura Oncology Ltd (FN3) has a reported market cap of $271.14M (data as of 2026-03-29).
What is FN3's P/E ratio?
The price-to-earnings (P/E) ratio for Racura Oncology Ltd (FN3) is 18.00 (data as of 2026-03-29).
Does Racura Oncology Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Racura Oncology Ltd (FN3). Check the MyAverix Finance app for the latest dividend data.
What sector is Racura Oncology Ltd in?
Racura Oncology Ltd (FN3) is classified in the Healthcare sector (Biotechnology industry).
What exchange is FN3 listed on?
FN3 is listed on F.
What is Racura Oncology Ltd's net margin?
Racura Oncology Ltd (FN3) reports a net margin of -270.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.